BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15350014)

  • 1. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria.
    Ravaioli M; Ercolani G; Cescon M; Vetrone G; Voci C; Grigioni WF; D'Errico A; Ballardini G; Cavallari A; Grazi GL
    Liver Transpl; 2004 Sep; 10(9):1195-202. PubMed ID: 15350014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.
    Toso C; Trotter J; Wei A; Bigam DL; Shah S; Lancaster J; Grant DR; Greig PD; Shapiro AM; Kneteman NM
    Liver Transpl; 2008 Aug; 14(8):1107-15. PubMed ID: 18668667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
    Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
    Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
    Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria.
    Ju MK; Choi GH; Huh KH; Joo DJ; Kim SJ; Choi J; Kim MS; Kim SI; Kim YS
    Hepatogastroenterology; 2010; 57(101):819-25. PubMed ID: 21033236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
    Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):406-9. PubMed ID: 24670459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of alfa fetoprotein to traditional criteria for hepatocellular carcinoma improves selection accuracy in liver transplantation.
    Sternby Eilard M; Holmberg E; Naredi P; Söderdahl G; Rizell M
    Scand J Gastroenterol; 2018 Aug; 53(8):976-983. PubMed ID: 30169974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.
    Suh KS; Cho EH; Lee HW; Shin WY; Yi NJ; Lee KU
    Dig Dis; 2007; 25(4):329-33. PubMed ID: 17960068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation.
    Mori S; Choi Y; Park MS; Kim H; Hong G; Yi NJ; Lee KW; Suh KS
    Hepatogastroenterology; 2014; 61(136):2353-8. PubMed ID: 25699382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
    Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
    Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.